We are live on ! Find out more
ACGN

Aceragen Inc

Delisted

ACGN was delisted on the 21st of August, 2023.

69 hedge funds and large institutions have $31.3M invested in Aceragen Inc in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 17

8% less capital invested

Capital invested by funds: $34M → $31.3M (-$2.76M)

18% less funds holding

Funds holding: 8469 (-15)

63% less call options, than puts

Call options by funds: $51K | Put options by funds: $138K

71% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 21

Holders
69
Holders Change
-15
Holders Change %
-17.86%
% of All Funds
1.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
22
Reduced
17
Closed
21
Calls
$51K
Puts
$138K
Net Calls
-$87K
Net Calls Change
-$97K

ACGN Hedge Fund Activity: Q1 2019 in Review

69 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Aceragen Inc (ACGN) for Q1 2019, worth a combined $31.3M — down 8.1% from $34M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ACGN and 6 opened new positions — a net loss of 15 holders — while 17 trimmed existing stakes and 22 added.

The largest buyer was Vanguard Group, adding an estimated $1.34M. The largest seller was Broadfin Capital, exiting entirely with an estimated $1.35M sold.

  • 69 institutional investors held Aceragen Inc (ACGN) as of Q1 2019, down from 84 in Q4 2018.
  • Funds reported $31.3M of Aceragen Inc stock for Q1 2019, down 8.1% quarter-over-quarter.
  • 6 funds opened new Aceragen Inc positions in Q1 2019 and 21 closed out, a net change of -15 holders.
  • The largest Aceragen Inc buyer in Q1 2019 was Vanguard Group, an estimated $1.34M added.
  • The largest Aceragen Inc seller in Q1 2019 was Broadfin Capital, an estimated $1.35M sold.

Based on aggregated 13F filings for Q1 2019.